Loading clinical trials...
Loading clinical trials...
Hypertrophic ObsructiveCardiomyopathy:Should the Mitral Valve be Addressed During Septal Myectomy?
Conditions
Interventions
The Septal myectom
Start Date
May 1, 2020
Primary Completion Date
May 1, 2022
Completion Date
June 1, 2022
Last Updated
April 1, 2020
NCT04349072
NCT04770142
NCT04141891
NCT04066777
NCT04686487
NCT04905173
Lead Sponsor
Assiut University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions